Close Menu


The firm believes that its molecular assay for the laboratory will help ease some of the supply chain issues hampering test rollout during the pandemic.

The assay, which resembles a pregnancy test, is authorized for use in laboratories certified under CLIA to perform as moderate- and highly-complexity tests.

The firm had been in stealth mode, but hopes to now attract partners to further commercialize its system for decentralized testing.